---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-021389"
form_type: "8-K"
ticker: "XTNT"
cik: "0001453593"
company_name: "Xtant Medical Holdings, Inc."
filed_at: "2025-11-10T23:59:59+00:00"
generated_at: "2026-05-16T22:20:15.942645+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# XTNT stockholders approve 12.3M share increase to 2023 equity plan at annual meeting

## Summary
- 12,300,000 additional shares approved for 2023 Equity Incentive Plan, effective immediately.
- Six director nominees elected with over 79M votes for each; no changes to board composition.
- Ratification of Grant Thornton as auditor for FY 2025; advisory vote on exec compensation approved.
- Stockholders voted 78.7M for 'every one year' frequency for future say-on-pay votes.
- Quorum of 69.2% (96.9M shares) present at meeting held Nov 7, 2025.

## SEC filing metadata
- accession: 0001493152-25-021389
- form_type: 8-K
- ticker: XTNT
- cik: 0001453593
- company_name: Xtant Medical Holdings, Inc.
- filed_at: 2025-11-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1453593/000149315225021389/0001493152-25-021389-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1453593/000149315225021389/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-021389
- JSON: https://secwatch.observer/filing/0001493152-25-021389.json
- Plain text: https://secwatch.observer/filing/0001493152-25-021389.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.